OpenAI's Medical AI Could Cut Drug Discovery from 15 Years to Months

AI in 10

AI in 10
OpenAI's Medical AI Could Cut Drug Discovery from 15 Years to Months
Apr 22, 2026
OpenAI just released GPT-Rosalind, an AI trained to think like a PhD biologist that could slash drug discovery timelines and costs by 30%. This isn't just another chatbot - it's potentially the biggest breakthrough in medicine since antibiotics.

Referenced Links:
OpenAI API Access
OpenAI Official Site
FDA Regulatory Information
AlphaFold Research


💬 Send Chuck a comment about this episode

Support the show

Want to go deeper with AI? A community of professionals is learning AI together right now at aihammock.com — show notes, links, tools, and real conversations about how to actually use AI in your life.